More Immutep Ltd news Immutep LtdASX: IMM New Biomarker Data from TACTI-002 trial in 1st line NSCLC Nov 3, 2023 at 1:37 AM UTC · Issued by Immutep Ltd As issuedPlain English Immutep Ltd has released a press release. View Attachment
